Cited by 106Gut microbiota and healthAcute Lymphoblastic Leukemia researchT-cell and Retrovirus Studies

An intact gut microbiome protects genetically predisposed mice against leukemia

Open access
Vicente-Dueñas, Carolina, Janssen, Stefan, Oldenburg, Marina, Auer, Franziska, González-Herrero, Inés, Casado-García, Ana, Isidro-Hernández, Marta, Raboso-Gallego, Javier +15 more·2020·Blood

Abstract

The majority of childhood leukemias are precursor B-cell acute lymphoblastic leukemias (pB-ALLs) caused by a combination of prenatal genetic predispositions and oncogenic events occurring after birth. Although genetic predispositions are frequent in children (>1% to 5%), fewer than 1% of genetically predisposed carriers will develop pB-ALL. Although infectious stimuli are believed to play a major role in leukemogenesis, the critical determinants are not well defined. Here, by using murine models of pB-ALL, we show that microbiome disturbances incurred by antibiotic treatment early in life were sufficient to induce leukemia in genetically predisposed mice, even in the absence of infectious stimuli and independent of T cells. By using V4 and full-length 16S ribosomal RNA sequencing of a series of fecal samples, we found that genetic predisposition to pB-ALL (Pax5 heterozygosity or ETV6-RUNX1 fusion) shaped a distinct gut microbiome. Machine learning accurately (96.8%) predicted genetic predisposition using 40 of 3983 amplicon sequence variants as proxies for bacterial species. Transplantation of either wild-type (WT) or Pax5+/- hematopoietic bone marrow cells into WT recipient mice revealed that the microbiome is shaped and determined in a donor genotype-specific manner. Gas chromatography-mass spectrometry (GC-MS) analyses of sera from WT and Pax5+/- mice demonstrated the presence of a genotype-specific distinct metabolomic profile. Taken together, our data indicate that it is a lack of commensal microbiota rather than the presence of specific bacteria that promotes leukemia in genetically predisposed mice. Future large-scale longitudinal studies are required to determine whether targeted microbiome modification in children predisposed to pB-ALL could become a successful prevention strategy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood.2019004381

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • An intact gut microbiome is necessary to prevent leukemia progression in genetically predisposed mice.

    “However, an intact gut microbiome was later shown to be necessary to prevent leukemia progression in genetically predisposed mice (92).”

    From The microbiome and human cancer (2021) · cites this paper as [92]

  • In blood cancers, preclinical data point to a delicate balance in which antibiotics or gut bacterial translocation can drive leukemic progression in hosts with genetic predisposition.

    “In hematologic malignancies, preclinical evidence suggests a careful balance, where either antibiotics or gut bacterial translocation can trigger leukemic progression in genetically-predisposed hosts (47, 92).”

    From The microbiome and human cancer (2021) · cites this paper as [92]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Research works printed but not linked: 5

  1. [4]4. GuZ, Churchman ML, Roberts KG, et al. PAX5driven subtypes of B-progenitor acute lymphoblastic leukemia. Nat Genet . 2019;51(2): 296-307.
  2. [13]13. malignancies: A single-center, populationbased cohort study. J Pediatr . 2018;197: 292-296.e3.
  3. [42]42. Knights D, Kuczynski J, Charlson ES, et al. Bayesian community-wide cultureindependent microbial source tracking. Nat Methods . 2011;8(9):761-763.
  4. [57]57. Matson V, Fessler J, Bao R, et al. The commensal microbiome is associated with antiPD-1 ef fi cacy in metastatic melanoma patients. Science . 2018;359(6371):104-108.
  5. [62]62. Shah A, Coleman MP. Increasing incidence of childhood leukaemia: a controversy reexamined. Br J Cancer . 2007;97(7): 1009-1012.

Cited by

Sorted by citations

Authors
Vicente-Dueñas, C., Janssen, S., Oldenburg, M., Auer, F., González-Herrero, I., Casado-García, A., Isidro-Hernández, M., Raboso-Gallego, J., Westhoff, P., Pandyra, A. A., Hein, D., Gössling, K. L., Alonso-López, D., De Las Rivas, J., Bhatia, S., García-Criado, F. J., García-Cenador, M. B., Weber, A. P. M., Köhrer, K., Hauer, J., Fischer, U., Sánchez-García, I., & Borkhardt, A.
Affiliations
  • Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain;
  • Justus-Liebig-Universität Gießen (DE)
  • Heinrich Heine University Düsseldorf (DE)
  • German Cancer Research Center (DE)
  • Consejo Superior de Investigaciones Científicas (ES)
  • Cluster of Excellence on Plant Sciences (DE)
  • Bioinformatics Unit, and
  • National Center for Tumor Diseases (DE)
Corresponding author
  • Janssen, Stefan
  • Oldenburg, Marina
  • Fischer, Ute
  • Borkhardt, Arndt
Venue
Blood
Published
2020-10-29
Volume
136
Issue
18
Pages
2003-2017
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W3086420584
Cited by
106
References
66
Citations by year
2026: 11 · 2025: 12 · 2024: 18 · 2023: 29 · 2022: 13 · 2021: 20 · 2020: 3
FWCI
5.27
Type
journal article
Language
en
Open access
Locations
  • Blood (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Hispana (acceptedVersion, cc-by-nc-nd)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
  • Gredos (University of Salamanca) (submittedVersion, cc-by-nc-nd)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Acute Lymphoblastic Leukemia research
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
Keywords
gut microbiota, pediatric leukemia, B-cell precursor acute lymphoblastic leukemia, genetic susceptibility, ETV6-RUNX1, commensal bacteria, leukemogenesis, bone marrow transplantation, microbiome-based prediction, leukemia prevention
MeSH terms
Gastrointestinal Microbiome, Animals, Disease Susceptibility, Feces, Female, Leukemia, Experimental, Mice, Inbred C57BL, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Mice, Knockout, Mice, PAX5 Transcription Factor, Dysbiosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review